News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
640,301 Results
Type
Article (58126)
Company Profile (215)
Press Release (581947)
Multimedia
Podcasts (162)
Webinars (24)
Section
Business (165573)
Career Advice (2482)
Deals (30521)
Drug Delivery (162)
Drug Development (78937)
Employer Resources (162)
FDA (16710)
Job Trends (13674)
News (299646)
Policy (32216)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2637)
Academic (1)
Accelerated approval (48)
Adcomms (37)
Allergies (171)
Alliances (42544)
ALS (200)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (471)
Approvals (16963)
Artificial intelligence (636)
Autoimmune disease (261)
Automation (45)
Bankruptcy (325)
Best Places to Work (10602)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (153)
Bladder cancer (193)
Brain cancer (76)
Breast cancer (761)
Cancer (5979)
Cardiovascular disease (472)
Career advice (2111)
Career pathing (45)
CAR-T (335)
CDC (73)
Celiac Disease (1)
Cell therapy (893)
Cervical cancer (47)
Clinical research (67965)
Collaboration (1945)
Company closure (6)
Compensation (1348)
Complete response letters (99)
COVID-19 (2827)
CRISPR (105)
C-suite (1036)
Cystic fibrosis (152)
Data (7407)
Decentralized trials (3)
Denatured (38)
Depression (174)
Dermatology (73)
Diabetes (558)
Diagnostics (6570)
Digital health (46)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (298)
Drug pricing (235)
Drug shortages (35)
Duchenne muscular dystrophy (290)
Earnings (69356)
Editorial (75)
Employer branding (20)
Employer resources (144)
Events (98313)
Executive appointments (1015)
FDA (20340)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1596)
Gene editing (229)
Generative AI (56)
Gene therapy (727)
GLP-1 (1156)
Government (4704)
Grass and pollen (8)
Guidances (401)
Healthcare (17346)
HIV (83)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (326)
Immuno-oncology (98)
Indications (171)
Infectious disease (3165)
Inflammatory bowel disease (212)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (271)
Interviews (463)
IPO (15133)
IRA (58)
Job creations (3391)
Job search strategy (1720)
JPM (70)
Kidney cancer (20)
Labor market (96)
Layoffs (646)
Leadership (47)
Legal (7562)
Liver cancer (107)
Longevity (26)
Lung cancer (800)
Lymphoma (428)
Machine learning (56)
Management (54)
Manufacturing (959)
MASH (191)
Medical device (12376)
Medtech (12449)
Mergers & acquisitions (16541)
Metabolic disorders (1543)
mRNA (221)
Multiple sclerosis (171)
NASH (23)
Neurodegenerative disease (411)
Neuropsychiatric disorders (115)
Neuroscience (3295)
Neurotech (2)
NextGen: Class of 2026 (5678)
Non-profit (4118)
Now hiring (44)
Obesity (766)
Opinion (318)
Ovarian cancer (214)
Pain (236)
Pancreatic cancer (300)
Parkinson's disease (353)
Partnered (29)
Patents (570)
Patient recruitment (647)
Peanut (63)
People (50915)
Pharmaceutical (46)
Pharmacy benefit managers (34)
Phase 1 (21128)
Phase 2 (29566)
Phase 3 (22928)
Pipeline (7637)
Policy (370)
Postmarket research (2625)
Preclinical (8992)
Press Release (37)
Prostate cancer (302)
Psychedelics (62)
Radiopharmaceuticals (341)
Rare diseases (1109)
Real estate (4936)
Recruiting (65)
Regulatory (25353)
Reports (48)
Research institute (2451)
Resumes & cover letters (410)
Rett syndrome (37)
RNA editing (25)
RSV (91)
Schizophrenia (182)
Series A (260)
Series B (200)
Service/supplier (9)
Sickle cell disease (114)
Special edition (28)
Spinal muscular atrophy (173)
Sponsored (52)
Startups (3151)
State (1)
Stomach cancer (21)
Supply chain (131)
Tariffs (104)
The Weekly (122)
Vaccines (1203)
Venture capital (116)
Weight loss (538)
Women's health (112)
Worklife (24)
Date
Today (152)
Last 7 days (649)
Last 30 days (2707)
Last 365 days (30014)
2026 (10033)
2025 (30086)
2024 (33769)
2023 (37948)
2022 (48573)
2021 (52303)
2020 (49619)
2019 (41269)
2018 (31195)
2017 (30731)
2016 (29412)
2015 (32878)
2014 (26168)
2013 (21822)
2012 (23245)
2011 (23518)
2010 (22038)
Location
Africa (794)
Alabama (81)
Alaska (6)
Arizona (290)
Arkansas (14)
Asia (37908)
Australia (6853)
California (12290)
Canada (3146)
China (1237)
Colorado (487)
Connecticut (557)
Delaware (366)
Europe (91232)
Florida (1843)
Georgia (374)
Hawaii (4)
Idaho (52)
Illinois (953)
India (80)
Indiana (553)
Iowa (24)
Japan (500)
Kansas (120)
Kentucky (46)
Louisiana (31)
Maine (81)
Maryland (1506)
Massachusetts (8896)
Michigan (299)
Minnesota (653)
Mississippi (5)
Missouri (136)
Montana (22)
Nebraska (24)
Nevada (128)
New Hampshire (70)
New Jersey (3292)
New Mexico (21)
New York (3253)
North Carolina (1590)
North Dakota (7)
Northern California (6202)
Ohio (355)
Oklahoma (18)
Oregon (37)
Pennsylvania (2396)
Puerto Rico (23)
Rhode Island (37)
South America (1135)
South Carolina (83)
South Dakota (2)
Southern California (4793)
Tennessee (192)
Texas (2055)
United States (43427)
Utah (318)
Virginia (291)
Washington D.C. (77)
Washington State (994)
West Virginia (4)
Wisconsin (132)
Wyoming (1)
640,301 Results for "texas children s cancer centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Picard Medical / SynCardia Highlights Total Artificial Heart Bridge to Transplant Case at Texas Children’s Hospital
April 15, 2026
·
5 min read
Press Releases
Texas Children’s Researcher Awarded Grant to Advance New Ways to Prevent and Treat Alzheimer’s Disease
March 25, 2026
·
4 min read
Mergers & acquisitions
Lilly wants to bridge cancer care gap with $300M ADC biotech buy
Eli Lilly is putting its obesity windfall to work again, striking a new deal to acquire CrossBridge Bio, a small Texas biotech known for its cancer tech.
April 14, 2026
·
1 min read
·
Gabrielle Masson
Lung cancer
Merck’s early PD-1/VEGF data competitive in lung cancer, but Summit ‘looms large’
While Merck’s PD-1/VEGF asset appears to match the performance of Summit Therapeutics’ ivonescimab, the pharma’s Phase 1/2 readout in non-small cell lung cancer still leaves analysts with some questions moving into later-stage development.
April 20, 2026
·
2 min read
·
Tristan Manalac
Job Trends
10 Companies Hiring in Texas Now
Looking for a biopharma job in Texas? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
April 8, 2026
·
1 min read
·
Angela Gabriel
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
BioOra and Cincinnati Children’s Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemia
April 14, 2026
·
6 min read
Bladder cancer
Merck, Pfizer’s Drug Combo ‘Rewrites the Standard of Care’ in Bladder Cancer
A combination of Merck’s Keytruda and Pfizer’s Padcev could offer a chemotherapy-free treatment alternative for patients with muscle-invasive bladder cancer, even those eligible for cisplatin treatment.
March 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
April 23, 2026
·
27 min read
Manufacturing
Novartis Names Texas City as Location of Its 5th US Radiopharmaceutical Facility
The Denton site is part of a network of manufacturing plants Novartis is building across the U.S. to make cancer drugs that must be shipped to patients quickly.
February 25, 2026
·
2 min read
·
Nick Paul Taylor
1 of 64,031
Next
